RETN and cancer: Further studies have indicated that circulating levels of resistin are positively correlated with increased tumor stage, size and lymph node metastasis in various cancer subtypes [21,24,25] and that the resistin treatment could promote tumor cell proliferation, angiogenesis, migration and chemotherapy resistance in both animal models and cultured cells [26,27,28,29,30].